Seattle Genetics (SGEN) Tops Q4 EPS by 59c, Revenues Beat; Offers FY20 Sales Outlook Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. SNDK
6. HTFL
7. ADYEN:NA
8. DVLT
9. ADYYF
10. WDAY

Go back to Seattle Genetics (SGEN) Tops Q4 EPS by 59c, Revenues Beat; Offers FY20 Sales Outlook Below Consensus

Seattle Genetics (SGEN) PT Raised to $120 at RBC Capital

February 5, 2020 6:26 AM EST

RBC Capital analyst Kennen MacKay raised the price target on Seattle Genetics (NASDAQ: SGEN) to $120.00 (from $113.00) while maintaining a Outperform rating.... More